Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics
NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian Armstrong, has raised $130 million in a Series B funding round to bolster its ambitions to slow or even reverse aspects of human aging.
The round, led by Kleiner Perkins, drew participation from prominent returning investors including Founders Fund, Dimension Capital, angel investor Elad Gil, Y Combinator CEO Garry Tan, and Stripe co-founder Patrick Collison, according to a statement.
New investors included former GitHub CEO Nat...
NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian Armstrong, has raised $130 million in a Series B funding round to bolster its ambitions to slow or even reverse aspects of human aging.
The round, led by Kleiner Perkins, drew participation from prominent returning investors including Founders Fund, Dimension Capital, angel investor Elad Gil, Y Combinator CEO Garry Tan, and Stripe co-founder Patrick Collison, according to a statement.
New investors included former GitHub CEO Nat...
6 hour ago